These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 17280482

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA.
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI, Schoen CU, Goebel W, Pilgrim S.
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intracellular bacteria as targets and carriers for vaccination.
    Mollenkopf H, Dietrich G, Kaufmann SH.
    Biol Chem; 2001 Apr; 382(4):521-32. PubMed ID: 11405217
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.
    Walcher P, Mayr UB, Azimpour-Tabrizi C, Eko FO, Jechlinger W, Mayrhofer P, Alefantis T, Mujer CV, DelVecchio VG, Lubitz W.
    Expert Rev Vaccines; 2004 Dec; 3(6):681-91. PubMed ID: 15606353
    [Abstract] [Full Text] [Related]

  • 13. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems.
    Pontes DS, de Azevedo MS, Chatel JM, Langella P, Azevedo V, Miyoshi A.
    Protein Expr Purif; 2011 Oct; 79(2):165-75. PubMed ID: 21704169
    [Abstract] [Full Text] [Related]

  • 14. Attenuated salmonella and Shigella as carriers for DNA vaccines.
    Xu F, Ulmer JB.
    J Drug Target; 2003 Oct; 11(8-10):481-8. PubMed ID: 15203916
    [Abstract] [Full Text] [Related]

  • 15. Advances in the development of bacterial vector technology.
    Kochi SK, Killeen KP, Ryan US.
    Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
    [Abstract] [Full Text] [Related]

  • 16. Bacteria as DNA vaccine carriers for genetic immunization.
    Schoen C, Stritzker J, Goebel W, Pilgrim S.
    Int J Med Microbiol; 2004 Oct; 294(5):319-35. PubMed ID: 15532991
    [Abstract] [Full Text] [Related]

  • 17. Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.
    Jalava K, Eko FO, Riedmann E, Lubitz W.
    Expert Rev Vaccines; 2003 Feb; 2(1):45-51. PubMed ID: 12901596
    [Abstract] [Full Text] [Related]

  • 18. Novel bacterial systems for the delivery of recombinant protein or DNA.
    Spreng S, Dietrich G, Niewiesk S, ter Meulen V, Gentschev I, Goebel W.
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):299-304. PubMed ID: 10727885
    [Abstract] [Full Text] [Related]

  • 19. Improving live attenuated bacterial carriers for vaccination and therapy.
    Loessner H, Endmann A, Leschner S, Bauer H, Zelmer A, zur Lage S, Westphal K, Weiss S.
    Int J Med Microbiol; 2008 Jan; 298(1-2):21-6. PubMed ID: 17702649
    [Abstract] [Full Text] [Related]

  • 20. Biological safety concepts of genetically modified live bacterial vaccines.
    Frey J.
    Vaccine; 2007 Jul 26; 25(30):5598-605. PubMed ID: 17239999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.